Company Filing History:
Years Active: 2018-2020
Title: Eui Jeoung Lee: Innovator in Pharmaceutical Composition for Inflammatory Bowel Diseases
Introduction
Eui Jeoung Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions aimed at treating inflammatory bowel diseases. With a total of 2 patents to his name, his work is paving the way for innovative treatments in this area.
Latest Patents
Eui Jeoung Lee's latest patents focus on pharmaceutical compositions that utilize extracts from various plants to combat inflammatory bowel diseases. One of his notable inventions is a pharmaceutical composition that includes a Stemonae Radix extract. This composition is designed to prevent or treat inflammatory bowel diseases caused by cigarette smoke. It works by suppressing the expression of inflammatory cytokines and reducing the level of MMP12 expression, which is known to damage essential proteins in the body. Another patent involves a mixture of extracts from multiple plants, including Stemonae Radix and Asparagi Tuber, aimed at ameliorating the effects of inflammatory bowel diseases. This composition also targets the suppression of inflammatory cytokines and aims to develop a safe and effective treatment for patients.
Career Highlights
Eui Jeoung Lee is affiliated with the University-industry Cooperation Group of Kyung Hee University. His work in this group emphasizes collaboration between academic research and industry applications, enhancing the practical impact of his inventions.
Collaborations
Eui Jeoung Lee has worked alongside notable colleagues, including Jin Ju Kim and Eun Jung Ko. Their collaborative efforts contribute to the advancement of research in the field of pharmaceuticals.
Conclusion
Eui Jeoung Lee's innovative work in pharmaceutical compositions for inflammatory bowel diseases showcases his commitment to improving health outcomes through research and invention. His contributions are significant in the ongoing battle against these challenging conditions.